retatrutide safety retatrutide clinical trial Availability & Timeline retatrutide safety trial results Retatrutide

Eli Lilly's retatrutide (LY3437943) was in Phase 3 trials as of 2025, with at least one stage expected to conclude in May 2026 [6]

Anti-Inflammatory effects of GLP-1-based therapies beyond glucose control

What to track 7-day free trial

Final Verdict Peak Wellness delivers exactly what it promises: fast, simplified access to GLP-1 treatment with flat pricing and transparent medical oversight

By understanding these connections and taking proactive steps to support hydration and electrolyte balance, you can harness the benefits of these diabetes and weight loss medications while maintaining the gut health thats so essential to your overall well-being

Early data show even greater weight loss and metabolic improvements than tirzepatide